Clinical Trials Browser

Interventional × NVP-BKM120 × Thoracic × Clear all

NCT01971489 2023-04-27

Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT01570296 2023-03-29

BKM120

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT02220855 2022-04-11

A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas

Phase 2 Completed

14 enrolled 14 charts

Thymoma

NCT01626209 2020-12-09

A Phase I Study of BKM120 in Adult Chinese Patients With Advanced Solid Tumors

Phase 1 Completed

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT02128724 2019-08-01

BKM120

Phase 1 Completed

21 enrolled 23 charts

Hypoxia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01487265 2019-03-06

Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib

Phase 2 Completed

37 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT01470209 2018-03-19

A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies

Phase 1 Completed

Lung Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT02194049 2018-01-09

Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer

Phase 1 Completed

Other solid neoplasmThoracic

Extensive Stage Small Cell Lung Cancer

NCT01723800 2016-09-20

PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT01297491 2016-03-11

BASALT-1

Phase 2 Completed

63 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT01501604 2015-09-17

BKM120 in Cancers With PIK3CA Activating Mutations

Phase 2 Withdrawn

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma